Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Human Polyclonal DEFB103A Primary Antibody for ICC, IHC (fro) - ABIN152261
Supp, Karpinski, Boyce: Expression of human beta-defensins HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes. in Burns : journal of the International Society for Burn Injuries 2004
Show all 14 Pubmed References
Human Polyclonal DEFB103A Primary Antibody for ELISA, WB - ABIN2473299
Ulick, Tedde, Mantero: Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. in The Journal of clinical endocrinology and metabolism 1990
Show all 2 Pubmed References
Human Polyclonal DEFB103A Primary Antibody for ELISA, WB - ABIN2473300
Harder, Bartels, Christophers, Schroder: Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. in The Journal of biological chemistry 2001
Show all 2 Pubmed References
hBD3 exhibits potent anti-periodontitis properties both in vitro and in vivo, and this effect may be correlated to inhibition of the nuclear factor-kappaB pathway and macrophage polarization.
Different dynamics and pathway of disulfide bonds reduction has been demonstrated for two human defensins, HD5 (show DEFA5 Antibodies) and HBD-3.
In this study, the results showed genetically modified (GM) milk containing human beta-defensin-3 (HBD3) was easy to be digested in simulated gastric fluid, and it did not have adverse effects on general and gastrointestinal (GI) tract health compared to conventional milk.
this study shows that hBD3 amplifies the response to bacterial DNA in both mouse and human immune cells in a TLR9 (show TLR9 Antibodies)-dependent manner
Direct interaction between SP-A or SAP01 and human BD-3 seemed to be responsible for the inhibitory effects on chemotaxis of mast cells.
Expression of hBD-1 (show DEFB1 Antibodies), hBD-2 (show DEFB4 Antibodies), hBD-3, and hBD-4 (show DEFB104A Antibodies) in healthy and chronic periodontitis gingiva.
Per duplication of mRNA in whole blood, the risk of being a carrier increased by 93% for IL17A (show IL17A Antibodies) and decreased by 35% for IFN-gamma (show IFNG Antibodies). Independent of carriage and DEFB promotor haplotype, a 1-unit increase in IFN-gamma (show IFNG Antibodies)/IL-17A (show IL17A Antibodies) mRNA ratio led to a 24% increase in HBD3 mRNA in wounded skin. A low Th1 (show TH1L Antibodies) to Th17 mRNA ratio increases the risk of colonization, with HBD3 being a potential link.
Analysis of TLR4 (show TLR4 Antibodies) and HBD3 expression in epithelial cells demonstrates the key role of the innate immune factors in the pathogenesis of inflammatory and destructive periodontal lesions.
study indicated that the expression of HBD-2 (show DEFB4 Antibodies) and HBD-3 mRNA and protein in lesions of cutaneous tuberculosis may be not consistent with that of tuberculids
epidermal growth factor receptor (EGFR (show EGFR Antibodies))activation via phosphorylation of EGFR (show EGFR Antibodies) via TAK1 (show MAP3K7 Antibodies)-p38alpha (show MAPK14 Antibodies) pathway, and subsequent internalization of EGFR (show EGFR Antibodies) are functionally linked to the induction of hBD3 in gastric epithelial cells infected with H. pylori.
Thus, oral epithelial cells dominantly control IL-17R-dependent responses to oropharyngeal candidiasis through regulation of BD3 expression.
C/EBPbeta (show CEBPB Antibodies) contributes to immunity to mucosal candidiasis during cortisone immunosuppression in a manner linked to beta-defensin 3 expression, but is apparently dispensable for the IL-17 (show IL17A Antibodies)-dependent response.
Stress decreases mouse beta-defensin-3 expression in the esophagus of mice with diabetes.
visfatin (show NAMPT Antibodies) enhances CAMP, hBD-2 (show DEFB4 Antibodies), hBD-3, and S100A7 (show S100A7 Antibodies) production in human keratinocytes and their orthologs in murine imiquimod-treated psoriatic skin.
this investigation revealed an indispensable role for BD3, BD4 (show DEFB4 Antibodies), and CRAMP in defense against F. solani-induced keratitis
SP-A (show SFTPA1 Antibodies) protects lung epithelium from tissue injury caused by BD3
Mouse beta-defensin 3 was strongly up-regulated in colonic epithelium of 15 (but not 5) week-old IL-2 (show IL2 Antibodies)(-/-) mice and in dextran-sulfate-induced chronic (but not acute) colitis, but not in IL-2 (show IL2 Antibodies)(+/-) 15-week-old mice.
Epithelial and mucosal tissues expressed bd3 and recombinant bd3 exhibits antifungal activity.
Murine beta-defensins BD2 (show DEFB4 Antibodies) and BD3 together promote resistance against corneal infection by Pseudomonas aeruginosa.
Mycobacterial infection induces the expression of mBD3 (show MBD3 Antibodies) and mBD4 (show MBD4 Antibodies), and both might participate in the control of mycobacterial growth.
Expression of the bovine DEFB103 gene was surveyed in 27 tissues and transcript was most abundant in tissues with stratified squamous epithelium.
Defensins form a family of microbicidal and cytotoxic peptides made by neutrophils. Members of the defensin family are highly similar in protein sequence. This gene encodes defensin, beta 103B, which has broad spectrum antimicrobial activity and may play an important role in innate epithelial defense.
, beta-defensin 3
, defensin, beta 103
, defensin, beta 3
, defensin-like protein
, beta defensin-2
, beta-defensin 4
, defensin beta 3
, beta defensin 3
, beta-defensin 103A
, defensin, beta 103B
, Beta-defensin 6
, bovine neutrophil beta-defensin 3
, defensin, beta 103A
, beta-defensin 103B
, beta-defensin 300